PulmCrit – Before/after study of short-course steroid in COVID-19

One of the most notable controversies in COVID is when steroid might be beneficial.  Since steroid is widely available and inexpensive, this issue has escaped the attention of pharmaceutical companies.  Consequently, evidence surrounding this is extremely sparse.  Available evidence consists largely of retrospective studies which relate steroid administration to outcome.  Such studies are inherently flawed, … Continue reading PulmCrit – Before/after study of short-course steroid in COVID-19